Business
LevelJump Healthcare Corp. Q3 Yoy Revenue Increase of 32%; Q3 Adjusted EBITDA of $0.001 per Share
Toronto, Ontario--(Newsfile Corp. - November 30, 2022) - LevelJump Healthcare Corp. (TSXV: JUMP) ...
About this update from Leveljump Healthcare Corp.
[{"type":"text","content":"LevelJump Healthcare Corp. Q3 Yoy Revenue Increase of 32%; Q3 Adjusted EBITDA of $0.001 per ShareToronto, Ontario--(Newsfile Corp. - November 30, 2022) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) (\"LevelJump\" or the \"Company\"), a Canadian leader in B2B telehealth solutions, is pleased to announce today it has reported financial results for the third fiscal quarter ended September 30, 2022. All amounts are expressed in Canadian dollars.Financial and Operational HighlightsQ3 Adjusted EBITDA of $0.001 per share.Annual run rate is projected at over $12 million for 2023, including investments in associates at over $15 million.Revenues from Canadian Teleradiology Services, Inc. (\"CTS\") operations remain strong with $2,296,186 in revenues for the third quarter.Gross profit from CTS operations was $647,146 for the quarter, a 28.2% margin;Year over Year Q3 revenue increase of $556,721 an increase of 32%.Financial GuidanceManagement is currently estimating adjusted EBITDA of approximately $0.005 per share for Fiscal Year 2022 and approximately $0.016 for Fiscal Year 2023.Management Comments\"Revenues continue to increase as we implement our growth strategy of acquisition coupled with organic growth,\" said Mitch Geisler, CEO. \"We are forecasting increased adjusted EBITDA, leading to profitability as we move into 2023. Our in-patient care clinics along with our telehealth operations have allowed us to become a critical care healthcare company with multiple revenue streams.\"Non-GAAP Financial MeasuresThis news release contains financial terms (such as adjusted EBITDA) that are not considered under GAAP. Such financial measures, together with measures prepared in accordance with GAAP, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-GAAP measures may differ from other reporting issuers, and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-GAAP measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with GAAP. These financial measures are included because management uses this information to analyze operating performance and liquidity. For more informati...